Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» August 2012
August 2012
Game Changer for the Human Genome Sector?
Game Changer for the Human Genome Sector?
Minyanville
stem cells
ALS
Neuralstem
Pfizer
GSK
JNJ
GE Healthcare
Arthersys
FDA approves Ironwood, Forest Labs bowel drug
FDA approves Ironwood, Forest Labs bowel drug
Yahoo/AP
FDA
Ironwood
Forest Labs
Linzess
Sarepta rallies for second consecutive day
Sarepta rallies for second consecutive day
Marketwatch
Sarepta
eteplirsen
Duchenne Muscular Dystrophy
5 Pharmaceutical Companies With EMA Catalysts During The Next 3-12 Months
5 Pharmaceutical Companies With EMA Catalysts During The Next 3-12 Months
Seeking Alpha
Affymax
Arena Pharmaceuticals
Avanir
Curis
Dendreon
Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Yahoo/AP
Pfizer
immune therapy
VLST
CP-870
893
Generics Will Drive Mylan Higher By 2013
Generics Will Drive Mylan Higher By 2013
Seeking Alpha
Mylan
generics
Bristol-Myers Squibb
Merck
Pfizer
Teva Pharmaceuticals
J&J Will Pay $181 Million To Settle Risperdal Ad Claims
J&J Will Pay $181 Million To Settle Risperdal Ad Claims
Bloomberg
Risperdal
JNJ
settlements
advertising
Pfizer Loses Bid To Dismiss Fen-Phen Lung Ailment Suits
Pfizer Loses Bid To Dismiss Fen-Phen Lung Ailment Suits
Bloomberg
Pfizer
Fen-Phen
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
tivantinib
Arqule
lung cancer
Tarceva
Roche
Astellas
Zalicus: Ready To Rebound
Zalicus: Ready To Rebound
Seeking Alpha
Zalicus
Exalgo
Z160
Synavive
Prednisporin
Z944
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »